Jasmin Tiro to Alphapapillomavirus
This is a "connection" page, showing publications Jasmin Tiro has written about Alphapapillomavirus.
Connection Strength
1.960
-
Human Papillomavirus Vaccination Before and During the COVID-19 Pandemic. JAMA Netw Open. 2022 09 01; 5(9):e2234000.
Score: 0.844
-
Effect of Patient Characteristics on Uptake of Screening Using a Mailed Human Papillomavirus Self-sampling Kit: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2022 Nov 01; 5(11):e2244343.
Score: 0.213
-
Design of a pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake in a U.S. healthcare system: The STEP trial. Contemp Clin Trials. 2022 11; 122:106960.
Score: 0.213
-
Variation in the receipt of human papilloma virus co-testing for cervical screening: Individual, provider, facility and healthcare system characteristics. Prev Med. 2022 01; 154:106871.
Score: 0.199
-
T Cell Receptor Repertoires Acquired via Routine Pap Testing May Help Refine Cervical Cancer and Precancer Risk Estimates. Front Immunol. 2021; 12:624230.
Score: 0.191
-
Reactions of women underscreened for cervical cancer who received unsolicited human papillomavirus self-sampling kits. J Med Screen. 2020 09; 27(3):146-156.
Score: 0.174
-
One in four California adolescent girls have had human papillomavirus vaccination. Policy Brief UCLA Cent Health Policy Res. 2009 Feb; (PB2009-3):1-6.
Score: 0.082
-
Cost-effectiveness studies of HPV self-sampling: A systematic review. Prev Med. 2020 03; 132:105953.
Score: 0.044